Results 191 to 200 of about 3,755 (249)

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

Letter to the Editor. [PDF]

open access: yesAm J Occup Ther
Brown T   +3 more
europepmc   +1 more source

Samen bewegen we anders: hoe de inzet van zintuigen bij onderzoek helpt om ableism te ontmantelen en toegankelijke methoden te ontwerpen

open access: yesLocus
Meike Heessels   +6 more
doaj  

Calling on the USPSTF to Address Ableism and Structural Ableism

JAMA, 2023
In this Viewpoint, the authors urge the USPSTF to undertake a comprehensive effort to ensure its recommendations systematically consider the effects of ableism and structural ableism on individuals with disability.
Dimitri A, Christakis, Lisa I, Iezzoni
openaire   +2 more sources

Home - About - Disclaimer - Privacy